latest update:
[RxAtlas]

drug summary · 2 NDC codes

Jadenu 360 mg/1

deferasirox

HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.

dataset id 96180NDC codes 2application NDA206910RxCUI —

Facts

Field definitions, types, and provenance rules are in the data dictionary.

generic namedeferasirox
active ingredientsDEFERASIROX
dosage formTABLET, FILM COATED
routeORAL
strength360 mg/1
marketing statusNDA
DEA schedulenot reported
application numberNDA206910
ATC codenot reported
RxCUInot reported
manufacturerNovartis Pharmaceuticals Corporation
product typeHUMAN PRESCRIPTION DRUG
pharmacologic classCytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]

NDC codes

2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.

NDCPackage description
00078065615—
0078-0656—

Other deferasirox products

5 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.

Work with this record

  • Field definitions

    Types, scope, and provenance rules for every exported field.

  • REST API

    Query the same gate-backed records programmatically.

  • Evaluation sample

    Download a bounded slice before buying.

  • $29 API Pass

    Seven days of REST and MCP access to the full catalogue; credited toward the licence.